3.2. Cognitive Impairment in AUD Patients Alters Plasma Concentrations of HMGB1, RAGE, ROS/RNS, ApoD, and NRF2 Compared to AD and Control Groups. This evidence concerns the gene APOD and Cognitive impairment.